Skip to main content
Signal8

InMed Pharmaceuticals Inc. (MTRI) AI Dilution Summary

Updated Nov 10, 2026

Cash was $1,094,488 at 2026-09-30, against estimated monthly burn of $380,781. The company also has an active at-the-market program with H.C. Wainwright & Co., LLC, authorised to $1,213,648. Dilution here is driven primarily by the Yorkville equity line, which has $3,543,609 remaining of a $10,000,000 commitment through its 2027-01-01 term end.